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there has been a growing interest in alternative products and many
individuals - including those with knee complaints - seek such sol-
utions. Rosehip products are sold as a nutraceutical, which is particular
popular among persons with knee complaints. Biomechanical gait
analysis is a method to objectively and quantitatively measure the
function and usage of a joint, e.g. the knee, during functional tasks,
such as walking. Gait analysis is objective and sensitive to change in
mobility limitations and allow for detailed descriptions of the bio-
mechanical function of the knee at the joint level. Thus, gait analysis
may provide information about isolated changes in the function of the
knee joint that is not readily available from existing self-reported
outcomes.
The purpose of this study was to evaluate the efﬁcacy of a specialized
rosehip powder nutraceutical on the biomechanical function of the
knee joint during walking in subjects with knee-related walking limi-
tations in comparison with placebo.
Methods: Randomized, participant and outcome assessor blinded
trial (ClinicalTrials.gov Identiﬁer: NCT01927848). Eligible participants
had to have self-reported knee-related walking limitations. Partic-
ipants were randomly allocated (1:1) to receive 3 capsules/day of
either Rosehip powder or identically appearing placebo capsules for
12 weeks. To assess knee joint biomechanics during walking, 3-
dimensional gait analyses were used, from which change from
baseline in the peak resultant knee moment was pre-speciﬁed as
primary outcome. Secondary gait outcomes included changes from
baseline in sagittal and frontal plane knee joint moments, knee joint
kinematics, peaks in the vertical ground reaction forces, and self-
selected walking speeds. According to the protocol the analyses were
based on the ‘Intention-To-Treat’ population, deﬁned as all random-
ized participants using baseline observation carried forward impu-
tation for those with missing data. Analyses of covariance adjusting
for the level at baseline were used to determine differences between
groups (95% conﬁdence intervals) in the changes from baseline at
follow-up.
Results: 100 participants were randomized to Rosehip (n¼50) or pla-
cebo (n¼50) and deﬁned the ‘Intention-To-Treat’ population. Of these
94 completed the study (47 and 47, respectively). Summaries of baseline
values and changes are presented in Table 1. There were statistically
signiﬁcant group differences in the change from baseline in the primary
outcome (table 1) and in the sagittal plane moments and kinematics
during the stance phase of walking (Table 1) with the Rosehip group
exhibiting greater joint moments and more knee joint ﬂexion during
walking than the Placebo group following the intervention.
Conclusions: A daily intake of Rosehip powder for 12 weeks sig-
niﬁcantly improved important indices of knee joint function and
dynamics during walking compared to placebo in persons with knee-
related walking limitations. These promising results support that bio-
mechanical gait analysis is a sensitive instrument to capture changes in
biomechanical aspects of mobility limitations.
Funding: This study was supported by Orkla Health.
Trial registration: ClinicalTrials.gov: NCT01927848
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ASSESSING NEUROMUSCULAR CONTROL IN KNEE OSTEOARTHRITIS
S.L. Smith, J. Woodburn, M. Steultjens. Glasgow Caledonian Univ.,
Glasgow, United Kingdom
Purpose: Individuals with knee osteoarthritis (KOA) exhibit reduced
muscles strength and proprioception. The interaction of muscle weak-
ness and proprioception has been suggested to be predictive of func-
tional outcomes in independent cohorts. It is thought that the poor
muscle strength and proprioception impairs neuromuscular control
which negatively impacts on health outcomes in KOA. The purpose of
the study was to assess how biomechanical impairments associated
with KOA determine the loss of neuromuscular control and its sub-
sequent impact on health outcomes in KOA.
Methods: Biomechanical impairments of 18 symptomatic KOA partic-
ipants (62.7 ± 9.1 yrs; 29.7 ±5.2 kg/m2) were assessed, including iso-
metric muscle strength of the knee ﬂexors and extensors and passive
movement sense (proprioception). Neuromuscular control was deter-
mined from submaximal force accuracy and steadiness and muscle co-
activation during stair ascent for anterior-posterior and medial-lateral
muscles. Knee injury and Osteoarthritis Outcome Score (KOOS)
domains where used to assess pain, symptoms, activities of daily living(ADL), sports and recreation and quality of life (QOL). Linear regression
was performed to assess if biomechanical impairments predict neuro-
muscular control and Pearson’s correlation were performed to assess
the relationship between neuromuscular control and health outcomes.
Results: Biomechanical impairments (muscle strength and proprio-
ception) signiﬁcantly predicted loss of neuromuscular control outcome
measures: force accuracy (R2 ¼ 0.546, P ¼ 0.01), muscle co-activation
both hamstrings - quadriceps (R2 ¼ 0.525, P ¼ 0.013), and vastus lat-
eralis - vastus medialis (R2 ¼ 0.800, P ¼ 0.001), but not force steadiness
(R2¼ 0.192, P¼ 0.378). Neuromuscular control measures force accuracy
and force steadiness were weakly correlated with all KOOS domains in
participants with KOA (r ¼ -0.111 - -0.320; r ¼ 0.122 - -0.178; force
accuracy and steadiness respectively). Muscle co-activation, anterior-
posterior and medial-lateral was weakly correlated with all KOOS
domains for participants with KOA (r ¼ -0.098 - 0.244; r ¼ -0.079 -
0.293; anterior-posterior and medial-lateral respectively).
Conclusions:Muscle weakness and poor proprioception predict loss of
neuromuscular control in participants with KOA. This suggests that both
passive and active joint structures may inﬂuence neuromuscular con-
trol. When looking at the impact loss of neuromuscular control has on
the health outcomes of KOA, force accuracy and steadiness measure
strongly correlated with health outcomes in control participants,
whereby good force accuracy measures predicted good health out-
comes, however, this relationship was weak in participants with KOA.
The muscle co-activation measures of neuromuscular control showed
weak relationship with health outcomes for both KOA and control
participants.
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GREATER PEAK VERTICAL GROUND REACTION FORCE AND VERTICAL
GROUND REACTION FORCE LOADING RATE DURING WALKING GAIT
ARE ASSOCIATED WITH A LOWER SERUM RATIO OF COLLAGEN
TURNOVER IN INDIVIDUALS WITH ANTERIOR CRUCIATE LIGAMENT
RECONSTRUCTION
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Purpose: Patients that sustain an anterior cruciate ligament (ACL)
injury and undergo surgical ACL reconstruction (ACLr) are at high risk
for developing posttraumatic osteoarthritis (PTOA). The pathogenesis of
PTOA following ACLr involves alterations in collagen metabolism and
aberrant lower extremity movement biomechanics. Higher mechanical
loading has been found to negatively affect articular cartilage health
and it has been hypothesized that altered knee loading during gait may
hasten the development of PTOA following ACLr. Speciﬁcally, the peak
amplitude and the loading rate for the vertical ground reaction force
(vGRF) during the stance phase of gait may inﬂuence collagen metab-
olism in the knee of individuals with ACLr. The purpose of the study was
to determine the association between serum biomarkers of collagen
breakdown and synthesis and peak vGRF and the vGRF loading rate in
the reconstructed limb of individuals with ACLr. We hypothesize that
higher peak vGRF and vGRF loading rate will associate with higher
collagen breakdown relative to synthesis.
Methods: Nineteen participants with unilateral ACLr participated (58%
female, 21.0 ± 2.4 yr, 42.5 ± 30.6 months post ACLr, 72.6 ± 16.4 kg, 1.7 ±
0.1 m). Resting blood was collected from each participant, and sera
samples stored at -80oC until later analysis. Participants performed ﬁve
successful gait trials at a self-selected walking speed; the consistency of
inter-trial gait speed was monitored with timing gates. Successful gait
trials included striking two force plates that were embedded in a 6m
walkway. Kinetic data were visually inspected (MotionMonitor®
Acquisition, Visualization & Biomechanical Analysis Software) before
being ﬁltered and processed with in-house algorithms (LabVIEW v
12.0). Peak vGRFs were extracted from the ﬁrst 50% of the stance phase
of gait and vGRF loading rate was measured from heel strike detection
to the point of peak vGRF. The bodyweight (BW) of each participant was
used to normalize peak vGRF (%BW) and vGRF loading rate was nor-
malized to BW/ seconds (%BW/s). Sera were assessed for collagen
breakdown (collagen type II cleavage product [C2C]) and synthesis
(collagen type II C-propeptide [CPII]) concentrations using a speciﬁc
enzyme-linked immunosorbent assay (IBEX Technologies, Inc.). Within
assay coefﬁcients of variation were < 10%. We individually analyzed
